IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NICHOLAS A SANCHEZ

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1588160279
CMS profile
10998354
Location
HOUSTON, TX

General Payments · PY2021–2024

$3,809.30

  • Reported across 188 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,055.57

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Physician Assistant TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,055.57 53

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $203.96 9
Merck Sharp & Dohme Corporation $181.28 8
Novo Nordisk AS $165.55 10
Amgen Inc. $133.98 9
Actelion Pharmaceuticals US, Inc. $91.13 3
Boehringer Ingelheim Pharmaceuticals, Inc. $87.30 4
Janssen Pharmaceuticals, Inc $57.84 3
Acerta Pharma LLC $48.34 3
IMPULSE DYNAMICS (USA) INC. $27.83 1
Lilly USA, LLC $21.16 1
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.77 1
Azurity Pharmaceuticals, Inc. $18.43 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $220.28 11
PY2022 $621.50 21
PY2023 $1,911.95 103
PY2024 $1,055.57 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $29.43 01/10/2024 Food and Beverage Undisputed 01/23/2026 1078917877 CMS
Actelion Pharmaceuticals US, Inc. $32.25 03/28/2024 Food and Beverage Undisputed 01/23/2026 1078917113 CMS
Actelion Pharmaceuticals US, Inc. $29.45 06/25/2024 Food and Beverage Undisputed 01/23/2026 1078917883 CMS
Amgen Inc. $19.17 01/31/2024 Food and Beverage Undisputed 01/23/2026 1117373342 CMS
Amgen Inc. $17.57 02/14/2024 Food and Beverage Undisputed 01/23/2026 1117373344 CMS
Amgen Inc. $6.75 03/08/2024 Food and Beverage Undisputed 01/23/2026 1117373346 CMS
Amgen Inc. $18.33 03/18/2024 Food and Beverage Undisputed 01/23/2026 1117373348 CMS
Amgen Inc. $17.57 05/15/2024 Food and Beverage Undisputed 01/23/2026 1117373350 CMS
Amgen Inc. $17.51 06/05/2024 Food and Beverage Undisputed 01/23/2026 1117373352 CMS
Amgen Inc. $17.22 07/22/2024 Food and Beverage Undisputed 01/23/2026 1117373354 CMS
Amgen Inc. $14.67 08/28/2024 Food and Beverage Undisputed 01/23/2026 1117373356 CMS
Amgen Inc. $5.19 09/20/2024 Food and Beverage Undisputed 01/23/2026 1117373358 CMS
AstraZeneca Pharmaceuticals LP $18.68 04/15/2024 Food and Beverage Undisputed 01/23/2026 1104509362 CMS
AstraZeneca Pharmaceuticals LP $15.55 05/06/2024 Food and Beverage Undisputed 01/23/2026 1104571438 CMS
AstraZeneca Pharmaceuticals LP $14.11 10/02/2024 Food and Beverage Undisputed 01/23/2026 1104297892 CMS
Azurity Pharmaceuticals, Inc. $18.43 02/13/2024 Food and Beverage Undisputed 01/23/2026 1134020976 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.66 02/09/2024 Food and Beverage Undisputed 01/23/2026 1118068790 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.79 04/01/2024 Food and Beverage Undisputed 01/23/2026 1118068792 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.16 06/10/2024 Food and Beverage Undisputed 01/23/2026 1118068796 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.69 08/30/2024 Food and Beverage Undisputed 01/23/2026 1118068794 CMS
Impulse Dynamics (USA) Inc. $27.83 01/23/2024 Food and Beverage Undisputed 01/23/2026 1100417659 CMS
Janssen Pharmaceuticals, Inc $21.78 02/12/2024 Food and Beverage Undisputed 01/23/2026 1078203643 CMS
Janssen Pharmaceuticals, Inc $13.92 06/25/2024 Food and Beverage Undisputed 01/23/2026 1078204045 CMS
Janssen Pharmaceuticals, Inc $22.14 07/30/2024 Food and Beverage Undisputed 01/23/2026 1078205433 CMS
Lilly USA, LLC $21.16 04/18/2024 Food and Beverage Undisputed 01/23/2026 1135933840 CMS
Merck Sharp & Dohme LLC $21.72 01/04/2024 Food and Beverage Undisputed 01/23/2026 1141901418 CMS
Merck Sharp & Dohme LLC $23.65 02/23/2024 Food and Beverage Undisputed 01/23/2026 1141798937 CMS
Merck Sharp & Dohme LLC $23.65 04/04/2024 Food and Beverage Undisputed 01/23/2026 1141946011 CMS
Merck Sharp & Dohme LLC $21.50 05/03/2024 Food and Beverage Undisputed 01/23/2026 1141798931 CMS
Merck Sharp & Dohme LLC $20.33 07/26/2024 Food and Beverage Undisputed 01/23/2026 1141798921 CMS
Merck Sharp & Dohme LLC $26.71 08/15/2024 Food and Beverage Undisputed 01/23/2026 1141798933 CMS
Merck Sharp & Dohme LLC $21.54 10/01/2024 Food and Beverage Undisputed 01/23/2026 1141798935 CMS
Merck Sharp & Dohme LLC $22.18 10/18/2024 Food and Beverage Undisputed 01/23/2026 1141798939 CMS
Novartis Pharmaceuticals Corporation $21.46 01/25/2024 Food and Beverage Undisputed 01/23/2026 1087196403 CMS
Novartis Pharmaceuticals Corporation $19.62 03/08/2024 Food and Beverage Undisputed 01/23/2026 1087196413 CMS
Novartis Pharmaceuticals Corporation $29.03 04/03/2024 Food and Beverage Undisputed 01/23/2026 1087196409 CMS
Novartis Pharmaceuticals Corporation $22.09 05/07/2024 Food and Beverage Undisputed 01/23/2026 1087196421 CMS
Novartis Pharmaceuticals Corporation $24.62 06/12/2024 Food and Beverage Undisputed 01/23/2026 1087196427 CMS
Novartis Pharmaceuticals Corporation $21.65 07/19/2024 Food and Beverage Undisputed 01/23/2026 1087196431 CMS
Novartis Pharmaceuticals Corporation $20.17 08/13/2024 Food and Beverage Undisputed 01/23/2026 1087196433 CMS
Novartis Pharmaceuticals Corporation $22.85 10/04/2024 Food and Beverage Undisputed 01/23/2026 1087196439 CMS
Novartis Pharmaceuticals Corporation $22.47 10/28/2024 Food and Beverage Undisputed 01/23/2026 1087196445 CMS
Novo Nordisk Inc $16.83 02/20/2024 Food and Beverage Undisputed 01/23/2026 1100637264 CMS
Novo Nordisk Inc $17.02 03/23/2024 Food and Beverage Undisputed 01/23/2026 1100269554 CMS
Novo Nordisk Inc $15.95 04/18/2024 Food and Beverage Undisputed 01/23/2026 1100625008 CMS
Novo Nordisk Inc $17.36 05/29/2024 Food and Beverage Undisputed 01/23/2026 1100263560 CMS
Novo Nordisk Inc $7.77 06/21/2024 Food and Beverage Undisputed 01/23/2026 1100370069 CMS
Novo Nordisk Inc $23.21 07/17/2024 Food and Beverage Undisputed 01/23/2026 1100606916 CMS
Novo Nordisk Inc $9.89 08/01/2024 Food and Beverage Undisputed 01/23/2026 1100578744 CMS
Novo Nordisk Inc $20.79 08/19/2024 Food and Beverage Undisputed 01/23/2026 1100240130 CMS
Novo Nordisk Inc $18.87 09/09/2024 Food and Beverage Undisputed 01/23/2026 1100527047 CMS
Novo Nordisk Inc $17.86 10/07/2024 Food and Beverage Undisputed 01/23/2026 1100351478 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.77 08/12/2024 Food and Beverage Undisputed 01/23/2026 1080673002 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.